(a) The Consortium is composed of 27 members, as follows:
(1) Eleven individuals, or their designees, who are members of the Consortium by virtue of their respective positions, as follows:
a. The Lieutenant Governor of the State of Delaware.
b. The Chair of the Behavioral and Mental Health Commission.
c. The Chair of the Center for Health Innovation.
d. The Chair of the Delaware Suicide Prevention Association.
e. The Chair of the Overdose Fatality Review Commission.
f. The Chair of the Addiction Action Committee.
g. The Chair of the Police Chiefs Council.
h. The Chair of the Mental Health Association in Delaware.
i. The Executive Director of the Ability Network of Delaware.
j. The Attorney General, as co-chair of the Prescription Opioid Settlement Distribution Commission.
k. The chair of the Local Government Committee of the Prescription Opioid Settlement Distribution Commission.
(b) Members serving by virtue of position may appoint a designee to serve in their stead and at their pleasure.
(c) Consortium working groups. — The Consortium shall create working groups in accordance with the recommendation of the Consortium.
(d) Terms of the Consortium members. — Governor appointed members are appointed for a term of 2 years.
(e) Consortium Chair. — The Consortium shall be chaired by an appointment of the Governor from the Consortium membership. The Chair is responsible for guiding the administration of the Consortium by, at a minimum, supervising the preparation and distribution of meeting notices, agendas, minutes, correspondence, and reports of the Consortium.
(f) Official action by the Consortium, including making findings and recommendations included in a report issued by the Consortium, requires the approval of a majority of the total members of the Consortium.